A Phase 2 Single-Arm Open-Label Multicenter Study of the Clinical Activity and Safety of Enzalutamide in Patients With Advanced Androgen Receptor-Positive Triple-Negative Breast Cancer
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to determine if enzalutamide is safe and effective in the treatment of patients with advanced breast cancer.
Description
The purpose of this study is to determine if enzalutamide is safe and effective in the treatment of patients with advanced breast cancer.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: Female
Updated on
24 Apr 2024.
Study ID: 1308124852
